ALKS vs VRTX · P/E 14, rev $1.56B vs P/E 30, rev $12.00B
Alkermes Plc (ALKS) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the ALKS and VRTX stock pages for the full models.
Not investment advice.